Home Alzheimer’s Disease Stephen Schuster, MD, on Prioritizing Patients with Aggressive Lymphomas During COVID-19 Pandemic

Stephen Schuster, MD, on Prioritizing Patients with Aggressive Lymphomas During COVID-19 Pandemic

Stephen Schuster, MD, discussed how they are prioritizing patients with more aggressive lymphomas, with an emphasis on tumor volume and serum LDH levels during the COVID-19 pandemic.

Transcription:

We’ve gotten very good at assessing risk for not making it to collection. Basically, the 2 primary variables that we found are the tumor volume, the bulk of tumor that a patient has, also the serum LDH which effects the proliferative capacity or growth rate of the tumor. Patients with high serum LDH and high tumor volume are less likely to stay stable. Again, these are all patients that are refractory to existing therapy so it’s hard to keep them stable, although we try some things for so called ‘bridging’: steroids, novel agents, lenalidomide, ibrutinib for some patients, which occasionally will work. In these high volume, very-high risk for rapid progression, in those cases…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Cause of Alzheimer’s disease traced to mutation in common enzyme

submitted by /u/scotsman81 Continue Reading to the Source

Reflections on Living With an Incurable Illness : braincancer

(I’ve checked with the moderators to make sure this is appropriate and a good fit for this subreddit. I'm a very private person, and...

This Foramen Magnum Meningioma almost killed me 18 years ago.

submitted by /u/dkrem Continue Reading to the Source

Recent Comments